Statistics for Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models
Total visits
| views | |
|---|---|
| Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models | 2 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:81febee8-b1b5-44a0-b76e-0e2903f81390 | 80 |
| KCBT_22_2011642.pdf | 22 |
| java.util.UUID:9131a3cf-e79f-4136-9e53-9d18cf74ef6c | 2 |
| java.util.UUID:d558198e-fc9a-4788-a94f-e7aec0d1d253 | 1 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Indianapolis | 2 |